<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function - Botero Aguirre, JP - 2015 | Cochrane Library</title> <meta content="Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function - Botero Aguirre, JP - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010481.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function - Botero Aguirre, JP - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010481.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010481.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function" name="citation_title"/> <meta content="Juan Pablo Botero Aguirre" name="citation_author"/> <meta content="Hospital Pablo Tobon Uribe" name="citation_author_institution"/> <meta content="jpablo146epi@gmail.com" name="citation_author_email"/> <meta content="Alejandra Maria Restrepo Hamid" name="citation_author"/> <meta content="Hospital Pablo Tobon Uribe" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD010481.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/11/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010481.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010481.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010481.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Amphotericin B [adverse effects, *therapeutic use]; Antifungal Agents [adverse effects, *therapeutic use]; Chills [chemically induced]; Creatinine [blood]; Deoxycholic Acid [adverse effects, *therapeutic use]; Drug Combinations; Fever [chemically induced]; Kidney [*drug effects]; Nausea [chemically induced]; Randomized Controlled Trials as Topic; Vomiting [chemically induced]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010481.pub2&amp;doi=10.1002/14651858.CD010481.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="urvLIhM4";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010481\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010481\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010481.pub2",title:"Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function",firstPublishedDate:"Nov 23, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010481.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010481.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010481.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010481.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010481.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010481.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010481.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010481.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010481.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010481.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>31348 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010481.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/appendices#CD010481-sec-0079"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/table_n/CD010481StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/table_n/CD010481StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information#CD010481-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Juan Pablo Botero Aguirre</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information#CD010481-cr-0003">Alejandra Maria Restrepo Hamid</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information/en#CD010481-sec-0083">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 November 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010481.pub2">https://doi.org/10.1002/14651858.CD010481.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010481-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010481-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010481-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010481-abs-0005">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010481-abs-0001" lang="en"> <section id="CD010481-sec-0001"> <h3 class="title" id="CD010481-sec-0001">Background</h3> <p>The incidence of invasive fungal infections has increased globally as a result of several factors. Conventional amphotericin B (sodium deoxycholate) has been used as standard therapy for the treatment of invasive fungal infections; however, it is associated with adverse drug reactions, including acute kidney injury (AKI). New formulations of amphotericin B have aimed to improve the safety profile of the conventional formulation. </p> </section> <section id="CD010481-sec-0002"> <h3 class="title" id="CD010481-sec-0002">Objectives</h3> <p>This review aimed to assess the effects of amphotericin B deoxycholate versus liposomal amphotericin B on kidney function. </p> </section> <section id="CD010481-sec-0003"> <h3 class="title" id="CD010481-sec-0003">Search methods</h3> <p>We searched Cochrane Kidney and Transplant's Specialised Register to 10 March 2015 through contact with the Trials' Search Co‐ordinator using search terms relevant to this review. </p> </section> <section id="CD010481-sec-0004"> <h3 class="title" id="CD010481-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that compared amphotericin B sodium deoxycholate with liposomal amphotericin B. </p> </section> <section id="CD010481-sec-0005"> <h3 class="title" id="CD010481-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed studies for eligibility and conducted risk of bias evaluation. </p> </section> <section id="CD010481-sec-0006"> <h3 class="title" id="CD010481-sec-0006">Main results</h3> <p>We included 12 studies (2298 participants) in this review. Of these, 10 were meta‐analysed (2172 participants). Liposomal amphotericin B was found to be significantly safer than conventional amphotericin B in terms of serum creatinine increase (RR 0.49, 95% CI 0.40 to 0.59). There was significant decrease in all infusion‐related reactions in the liposomal group compared with the conventional group: fever (4 studies, 1092 participants): RR 0.39, 95% CI 0.28 to 0.55; I<sup>2</sup> = 32%); chills and/or rigours (5 studies, 1081 participants): RR 0.27, 95% CI 0.15 to 0.48; I<sup>2</sup> = 75%); fever and/or rigours (2 studies, 720 participants): RR 0.68, 95% CI 0.52 to 0.90; I<sup>2</sup> = 58%); nausea (6 studies, 1187 participants): RR 0.50, 95% CI 0.35 to 0.72; I<sup>2</sup> = 0%); and vomiting (3 studies, 1019 participants): RR 0.51, 95% CI 0.27 to 0.95; I<sup>2</sup> = 61%). Overall, risk of bias in included studies was low or unclear for most domains. However, blinding of participants and personnel, blinding of outcome assessment and other bias (funding) tended to have a high risk of bias. The sensitivity analysis performed did not change the significance of difference in favour of the liposomal formulation. Assessment for publication bias found that review results were robust. </p> </section> <section id="CD010481-sec-0007"> <h3 class="title" id="CD010481-sec-0007">Authors' conclusions</h3> <p>Current evidence suggests that liposomal amphotericin B is less nephrotoxic than conventional amphotericin B (when the effect on kidney function is measured as an increase in serum creatinine level equal to or greater than two‐fold from the baseline level). We also found that there were fewer infusion‐related reactions associated with the liposomal formulation. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010481-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010481-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010481-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010481-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010481-abs-0003" lang="en"> <h3>Which amphotericin B formulation better preserves kidney function among people with fungal infection? </h3> <p>Fungal infections can cause ill health, and in some cases, death. Conventional amphotericin B has been used for many years to treat fungal infection. Although effective, this drug can cause kidney damage in about eight of every ten patients treated. People with kidney damage have longer stays in hospital, increased healthcare costs, and higher numbers of deaths. </p> <p>To avoid the problems known to affect people who need treatment for fungal infection, new formulations of amphotericin B (called lipid‐associated) have been developed. Liposomal amphotericin B is a new formulation and is most often used in clinical practice to treat fungal infection. </p> <p>We searched the literature published up to 10 March 2015, and identified 12 studies (2298 participants) that compared conventional amphotericin B with liposomal amphotericin B. We were able to meta‐analyse 10 studies (2172 participants). Study quality was assessed as moderate overall. </p> <p>Liposomal amphotericin B was found to be associated with fewer kidney and infusion‐related reactions than conventional amphotericin B. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010481-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010481-sec-0074"></div> <h3 class="title" id="CD010481-sec-0075">Implications for practice</h3> <section id="CD010481-sec-0075"> <p>Liposomal amphotericin B is less nephrotoxic than conventional amphotericin B, but the high cost precludes routine use in many healthcare settings. Patients being considered to receive the liposomal formulation should be selected on the basis of diagnosis, concomitant nephrotoxic drugs, duration of therapy and dose of amphotericin B. In most included studies, premedication or saline loading was permitted to prevent infusion‐related reactions and nephrotoxicity, therefore, renal effect of each amphotericin B formulation is hard to establish. </p> </section> <h3 class="title" id="CD010481-sec-0076">Implications for research</h3> <section id="CD010481-sec-0076"> <p>Larger, well‐designed and adequately powered studies comparing conventional amphotericin B with liposomal amphotericin B (including other lipid based formulations) and final endpoints are needed to inform clinical decision making. If this approach is considered to be unethical, new biomarkers (neutrophil gelatinase‐associated lipocalin, cystatin‐C, N‐acetyl‐β‐d‐glucosaminidase, kidney injury molecule‐1, and α<sub>1</sub>‐microglobulin, among others) with better performance in early stage AKI should be considered for incorporation in clinical practice and investigated in few studies. </p> <p>Investigators should also consider adopting the recommendations of the CONSORT statement (<a href="./references#CD010481-bbs2-0053" title="MoherD , HopewellS , SchulzKF , MontoriV , GøtzschePC , DevereauxPJ , et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c869. [MEDLINE: 20332511] ">Moher 2010</a>) in the planning and conduct of new studies. </p> <p>Analyses of cost‐effectiveness would beneficial; there are currently insufficient efficacy, safety and quality data to inform cost‐effectiveness analyses. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010481-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010481-sec-0015"></div> <div class="table" id="CD010481-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Increase in serum creatinine (SCr) level ≥ two‐fold from baseline level</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients in treatment with amphotericin B<br/> <b>Settings:</b> inpatients<br/> <b>Intervention:</b> liposomal amphotericin B<br/> <b>Comparison:</b> conventional amphotericin B </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Conventional amphotericin B</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Liposomal amphotericin B</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Increase in SCr level: ≥ two‐fold from baseline level</b> <br/> SCr level (mg/dL) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.49</b> <br/> (0.40 to 0.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2172 (10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕<br/> <b>Moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>261 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>128 per 1000</b> <br/> (105 to 154) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The results obtained are consistent; sensitivity analysis was performed to see the influence of several factors in the effect estimate, however, the magnitude, the direction and the significance didn't change. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010481-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010481-sec-0016"></div> <p>The cause of increasing global incidence of invasive fungal infections has been attributed to a number of factors including invasive medical interventions, increased use of central venous catheters, long‐term hospital admissions and acquired or induced immunodeficiency (<a href="./references#CD010481-bbs2-0058" title="PfallerMA , DiekemaDJ . Epidemiology of invasive mycoses in North America. Critical Reviews in Microbiology2010;36(1):1–53. [MEDLINE: 20088682] ">Pfaller 2010</a>). The rise in incidence is notorious among immunocompromised and hospitalised patients with serious underlying diseases, although in developing countries, fungal infections also frequently affect healthy people (<a href="./references#CD010481-bbs2-0039" title="BrownGD , DenningDW , LevitzSM . Tackling human fungal infections. Science2012;336(6082):647. [MEDLINE: 22582229] ">Brown 2012</a>). </p> <p>The most common fungal pathogens in humans are <i>Candida</i> spp, <i>Cryptococcus neoformans</i> , <i>Pneumocystis jirovecii</i> , <i>Histoplasma capsulatum</i> , <i>Cryptoccocus gatii</i> , <i>Coccidoides posadasii</i> and <i>Aspergillus</i> spp<i>.</i> (<a href="./references#CD010481-bbs2-0039" title="BrownGD , DenningDW , LevitzSM . Tackling human fungal infections. Science2012;336(6082):647. [MEDLINE: 22582229] ">Brown 2012</a>; <a href="./references#CD010481-bbs2-0040" title="DelPoetaM , ChaturvediV . Cryptococcus and cryptococcosis in the twenty‐first century. Mycopathologia2012;173(5‐6):283–5. [MEDLINE: 22531978] ">Del Poeta 2012</a>; <a href="./references#CD010481-bbs2-0047" title="Husain S ,  WagenerMM ,  SinghN . Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerging Infectious Diseases2001;7(3):375‐81. [MEDLINE: 11384512] ">Husain 2001</a>; <a href="./references#CD010481-bbs2-0058" title="PfallerMA , DiekemaDJ . Epidemiology of invasive mycoses in North America. Critical Reviews in Microbiology2010;36(1):1–53. [MEDLINE: 20088682] ">Pfaller 2010</a>). In some European countries, annual incidence of fungaemia has been reported at between 2.2 and 11 episodes per 100,000 people (<a href="./references#CD010481-bbs2-0035" title="ArendrupMC , FuurstedK , Gahrn‐HansenB , SchonheyderHC , KnudsenJD , JensenIM , et al. Semi‐national surveillance of fungaemia in Denmark 2004‐2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clinical Microbiology &amp; Infection2008;14(5):487–94. [MEDLINE: 18294241] ">Arendrup 2008</a>; <a href="./references#CD010481-bbs2-0059" title="PoikonenE ,  LyytikäinenO ,  AnttilaVJ ,  KuuselaP ,  Koukila‐KähköläP ,  OllgrenJ ,  etal . Nosocomial candidaemia in a Finnish tertiary care centre during 1987‐2004. Scandinavian Journal of Infectious Diseases2009;41(8):590‐6. [MEDLINE: 19488931] ">Poikonen 2009</a>). In population‐based studies from the United States, reported rates ranged from 6 to 8.7 per 100,000 people (<a href="./references#CD010481-bbs2-0043" title="Hajjeh RA ,  SofairAN ,  HarrisonLH ,  LyonGM ,  Arthington‐SkaggsBA ,  MirzaSA ,  etal . Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population‐based active surveillance program. Journal of Clinical Microbiology2004;42(4):1519‐27. [MEDLINE: 15070998] ">Hajjeh 2004</a>). </p> <p>Among people admitted to intensive care units or who are immunocompromised, invasive fungal infections are responsible for significant morbidity and mortality. The AURORA project found that 16.5 cases of invasive fungal infections per 1000 admissions were caused by yeasts and 2.3 per 1000 admissions were caused by filamentous fungi (<a href="./references#CD010481-bbs2-0054" title="MontagnaMT , CaggianoG , LoveroG , DeGiglioO , CorettiC , CunaT , et al. Epidemiology of invasive fungal infections in the intensive care unit: Results of a multicenter Italian survey (AURORA Project). Infection2013;41(3):645–53. [MEDLINE: 23463186] ">Montagna 2013</a>). Although reported mortality rates for the most common pathogen ‐ <i>Candida</i> spp. ‐ varies, many studies report infection rates of up to 40% (<a href="./references#CD010481-bbs2-0057" title="ParamythiotouE , FrantzeskakiF , FlevariA , ArmaganidisA , DimopoulosG . Invasive fungal infections in the ICU: how to approach, how to treat. Molecules2014;19(1):1085‐119. [MEDLINE: 24445340] ">Paramythiotou 2014</a>). More than 1 million AIDS‐related deaths annually are due to invasive fungal infections and account for half of all deaths among this patient population (<a href="./references#CD010481-bbs2-0036" title="Armstrong‐JamesD , MeintjesG , BrownGD . A neglected epidemic: fungal infections in HIV/AIDS. Trends in Microbiology2014;22(3):120‐7. [MEDLINE: 24530175] ">Armstrong‐James 2014</a>). </p> <p>The magnitude of challenges associated with management of invasive fungal infections means that identification of novel antifungal agents and approaches to improve effectiveness and safety of currently available agents has become imperative. </p> <section id="CD010481-sec-0017"> <h3 class="title" id="CD010481-sec-0017">Description of the condition</h3> <p>Conventional amphotericin B (sodium deoxycholate) is a broad‐spectrum antifungal that has been used as standard therapy for treatment of many invasive fungal infections since its introduction to clinical practice in the 1950s (<a href="./references#CD010481-bbs2-0037" title="BassettiM , AversaF , BalleriniF , BenedettiF , BuscaA , CascavillaN , et al. Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients. Clinical Drug Investigation2011;31(11):745‐58. [MEDLINE: 21888451] ">Bassetti 2011</a>). Conventional amphotericin B has also been used to treat non‐fungal infections including visceral leishmaniasis and <i>Naegleria fowleri</i> primary amoebic meningoencephalitis. </p> <p>Although other classes of antifungal drugs, such as azoles and echinocandins, have been developed in recent years, amphotericin B sodium deoxycholate continues to be widely used as the primary agent for treatment of people with serious invasive fungal infections (<a href="./references#CD010481-bbs2-0050" title="Laniado‐LaborínR ,  Cabrales‐VargasMN . Amphotericin B: side effects and toxicity. Revista Iberoamericana de Micología2009;26(4):223‐7. [MEDLINE: 19836985] ">Laniado‐Laborín 2009</a>; <a href="./references#CD010481-bbs2-0056" title="Ostrosky‐ZeichnerL , MarrK , RexJH , CohenSH . Amphotericin B: time for a new “gold standard”. Clinical Infectious Diseases2003;37(3):415–25. [MEDLINE: 12884167] ">Ostrosky‐Zeichner 2003</a>). A significant limitation of amphotericin B sodium deoxycholate is its safety profile; it is associated with adverse effects, including acute kidney injury (AKI) (<a href="./references#CD010481-bbs2-0046" title="HorwitzE ,  ShavitO ,  ShouvalR ,  HoffmanA ,  ShapiroM ,  MosesAE . Evaluating real‐life clinical and economical burden of amphotericin‐B deoxycholate adverse reactions. International Journal of Clinical Pharmacy2012;34(4):611‐7. [MEDLINE: 22674178] ">Horwitz 2012</a>; <a href="./references#CD010481-bbs2-0052" title="MistroS , Maciel IdeM , deMenezesRG , MaiaZP , SchooleyRT , BadaroR . Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta‐analysis. Clinical Infectious Diseases2012;54(12):1774‐7. [MEDLINE: 22491505] ">Mistro 2012</a>) mediated by vasoconstriction and direct tubular toxicity. The reported incidence of nephrotoxicity varies widely; however, significant decrease in kidney function has been reported in over 80% of patients and is associated with higher mortality rates, length of hospital stay and costs (<a href="./references#CD010481-bbs2-0038" title="BatesDW , SuL , YuDT , ChertowGM , SegerDL , GomesDR , et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clinical Infectious Diseases2001;32(5):686–93. [MEDLINE: 11229835] ">Bates 2001</a>). </p> </section> <section id="CD010481-sec-0018"> <h3 class="title" id="CD010481-sec-0018">Description of the intervention</h3> <p>New lipid‐associated formulations have been developed to improve the safety profile of conventional amphotericin B including liposomal amphotericin B, amphotericin B lipid complex and amphotericin B colloidal dispersion (<a href="./references#CD010481-bbs2-0041" title="GraybillJR . Lipid formulations for amphotericin B: does the emperor need new clothes?. Annals of Internal Medicine1996;124(10):921–3. [MEDLINE: 8610924] ">Graybill 1996</a>; <a href="./references#CD010481-bbs2-0049" title="KleinbergM . What is the current and future status of conventional amphotericin B?. International Journal of Antimicrobial Agents2006;27 Suppl 1:12–6. [MEDLINE: 16707251] ">Kleinberg 2006</a>). These formulations appear to offer advantages over the conventional formulation, notably a marked decrease in nephrotoxicity (<a href="./references#CD010481-bbs2-0037" title="BassettiM , AversaF , BalleriniF , BenedettiF , BuscaA , CascavillaN , et al. Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients. Clinical Drug Investigation2011;31(11):745‐58. [MEDLINE: 21888451] ">Bassetti 2011</a>; <a href="./references#CD010481-bbs2-0055" title="NoguchiS ,  TakahashiN ,  ItoM ,  TeshimaK ,  YamashitaT ,  MichishitaY ,  etal . Safety and efficacy of low‐dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia. International Journal of Clinical Oncology2013;18(6):983‐7. [MEDLINE: 23076821] ">Noguchi 2013</a>). An earlier Cochrane review reported increased nephrotoxicity associated with amphotericin B deoxycholate compared with lipid soluble formulations (<a href="./references#CD010481-bbs2-0048" title="JohansenHK , GøtzschePC . Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD000969.pub2] ">Johansen 2014</a>); however, the patient population evaluated was limited to those with cancer and neutropenia and did not account for other patient populations at high risk of nephrotoxicity. </p> </section> <section id="CD010481-sec-0019"> <h3 class="title" id="CD010481-sec-0019">How the intervention might work</h3> <p>The liposomal formulation of amphotericin B incorporates the antifungal drug into a liposomal bilayer, composed for phospholipids and cholesterol. When the liposome reaches the fungal cell, it is disrupted and the drug is released into the fungal cell membrane where it binds to the ergosterol. The liposome keeps its integrity in the presence of mammalian cells resulting in minimal toxicity (<a href="./references#CD010481-bbs2-0034" title="Adler‐MooreJ , ProffittRT . AmBisome: liposomal formulation, structure, mechanism of action and pre‐clinical experience. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:21‐30. [MEDLINE: 11801577] ">Adler‐Moore 2002</a>). </p> </section> <section id="CD010481-sec-0020"> <h3 class="title" id="CD010481-sec-0020">Why it is important to do this review</h3> <p>The clinical relevance of nephrotoxicity is important when pharmacoeconomic analyses of lipid‐associated products are performed that attempt to assign secondary costs to amphotericin B nephrotoxicity. For a 70 kg patient, the estimated acquisition cost of liposomal amphotericin B at a dose of 5 mg/kg/day is approximately USD 1318.8/day; while the cost for amphotericin B deoxycholate at a dose 1 mg/kg/day is approximately USD 63.8/day, according to the average wholesale price (<a href="./references#CD010481-bbs2-0060" title="Truven Health Analytics. Micromedex. Thomson Reuters (Healthcare) Inc, 2014. ">RED BOOK 2014</a>). </p> <p>Given high acquisition costs, a review of pivotal kidney health endpoints may inform resource allocation decisions for liposomal amphotericin B use, particularly in resource‐limited settings. Other adverse effects of amphotericin B products, such as infusion–related reactions, should also be considered when assessing the relative cost–effectiveness of these agents. Data limitations meant that we evaluated the effects of amphotericin B sodium deoxycholate versus liposomal amphotericin B on kidney function according to a number of kidney function parameters. Liposomal amphotericin B was selected as the comparator because it is a widely used lipid‐associated formulation. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010481-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010481-sec-0021"></div> <p>This review aimed to assess the effects of amphotericin B deoxycholate versus liposomal amphotericin B on kidney function. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010481-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010481-sec-0022"></div> <section id="CD010481-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010481-sec-0024"> <h4 class="title">Types of studies</h4> <p>All RCTs and cluster‐RCTs comparing amphotericin B deoxycholate sodium versus liposomal amphotericin B were eligible for inclusion regardless of publication language. </p> </section> <section id="CD010481-sec-0025"> <h4 class="title">Types of participants</h4> <section id="CD010481-sec-0026"> <h5 class="title">Inclusion criteria</h5> <p>Patients diagnosed with proven, probable or possible invasive fungal infection were included, as well as those with documented or suspected neutropenia (absolute neutrophil count &lt; 500 cells/mm³), those considered at high risk for developing invasive fungal infection by investigators, and those with other infectious diseases where amphotericin B is used as primary treatment. </p> </section> <section id="CD010481-sec-0027"> <h5 class="title">Exclusion criteria</h5> <p>Patients receiving any form of parenteral amphotericin B within 10 days prior to study drug administration were excluded. </p> </section> </section> <section id="CD010481-sec-0028"> <h4 class="title">Types of interventions</h4> <p>Studies reporting patients receiving amphotericin B sodium deoxycholate alone or in combination with other licensed antifungal agents (control group) versus liposomal amphotericin B alone or in combination with other licensed antifungal agents (treatment group) irrespective of dose and/or duration of treatment were included. Amphotericin B formulations were administered intravenously<i>.</i> </p> </section> <section id="CD010481-sec-0029"> <h4 class="title">Types of outcome measures</h4> <section id="CD010481-sec-0030"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010481-list-0001"> <li> <p>Increase in serum creatinine (SCr) level ≥ than two‐fold from baseline.</p> </li> </ul> </p> </section> <section id="CD010481-sec-0031"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010481-list-0002"> <li> <p>50% increase in SCr occurring at any time during the study period</p> </li> <li> <p>Discontinuation of amphotericin B therapy due to nephrotoxicity as determined by the investigators </p> </li> <li> <p>Increase in SCr &gt; 2 mg/dL at any time during the study period</p> </li> <li> <p>Change in creatinine clearance (CrCl) from beginning to end of the study</p> </li> <li> <p>Infusion‐related reactions as determined by the investigators.</p> </li> </ol> </p> </section> </section> </section> <section id="CD010481-sec-0032"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010481-sec-0033"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Kidney and Transplant's Specialised Register to 10 March 2015 through contact with the Trials Search Co‐ordinator using search terms relevant to this review. The Specialised Register contains studies identified from the following sources. </p> <p> <ol id="CD010481-list-0003"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of renal‐related journals and the proceedings of major renal conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected renal journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Specialised register, are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD010481-sec-0080">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD010481-sec-0034"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD010481-list-0004"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD010481-sec-0035"> <h3 class="title" id="CD010481-sec-0035">Data collection and analysis</h3> <section id="CD010481-sec-0036"> <h4 class="title">Selection of studies</h4> <p>The search strategy described was used to obtain titles and abstracts of studies relevant to the review. Titles and abstracts were screened independently by two authors, who discarded studies that were not applicable. However, studies and reviews thought to potentially include relevant data or information on studies were retained initially. Two authors independently assessed retrieved abstracts, and where necessary the full text of studies to determine which satisfied the inclusion criteria </p> </section> <section id="CD010481-sec-0037"> <h4 class="title">Data extraction and management</h4> <p>Data extraction was carried out independently by two authors using a standardised data extraction form. Studies reported in languages other than English and Spanish were translated before assessment. Where more than one publication of one study existed, reports were grouped together and the publication with the most complete data was used in the analyses. Where relevant outcomes were only published in earlier versions, these data were used. Any discrepancies between published versions were to be highlighted. </p> </section> <section id="CD010481-sec-0038"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were assessed independently by two authors using the risk of bias assessment tool (<a href="./references#CD010481-bbs2-0045" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) (<a href="./appendices#CD010481-sec-0081">Appendix 2</a>). </p> <p> <ul id="CD010481-list-0005"> <li> <p>Was there an adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD010481-list-0006"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias) </p> </li> </ul> <ul id="CD010481-list-0007"> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD010481-sec-0039"> <h4 class="title">Measures of treatment effect</h4> <p>We reported estimates for dichotomous outcomes (e.g. numbers of patients with increased SCr ≥ two‐fold from baseline level) as risk ratio (RR) with associated 95% confidence interval (CI). We calculated measures of effect by applying the random‐effects model; the Mantel‐Haenszel method (<a href="./references#CD010481-bbs2-0051" title="MantelN , HaenszelW . Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute1959;22(4):719‐48. [PUBMED: 13655060] ">Mantel 1959</a>) was used to pool results. </p> </section> <section id="CD010481-sec-0040"> <h4 class="title">Unit of analysis issues</h4> <p>No cluster‐RCTs were found in the search. In studies with multiple arms (specifically those with two liposomal amphotericin B arms), data were pooled for both arms; where there were multiple arms, where one was not liposomal amphotericin B, conventional and liposomal formulation arms were included in the analysis. </p> </section> <section id="CD010481-sec-0041"> <h4 class="title">Dealing with missing data</h4> <p>Any further information required from the original author was requested by written correspondence (e.g. e‐mailing and/or writing to corresponding author/s) and any relevant information obtained in this manner was included in the review. For all outcomes, we presented data for all randomised participants where reported; otherwise, estimates were based on complete case data. </p> </section> <section id="CD010481-sec-0042"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered clinical heterogeneity (the degree to which RCTs varied in terms of participants, interventions, doses, duration and frequency) and statistical heterogeneity. Statistical heterogeneity was assessed using the Chi² test (P &lt; 0.10 was considered to indicate statistically significant heterogeneity) in conjunction with the I² statistic (<a href="./references#CD010481-bbs2-0044" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). I² values of 25%, 50% and 75% correspond to low, medium and high levels of heterogeneity. </p> </section> <section id="CD010481-sec-0043"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to investigate potential for small study bias by constructing and interpreting funnel plots (<a href="./references#CD010481-bbs2-0045" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Our analysis found no substantial risk for small study bias. </p> </section> <section id="CD010481-sec-0044"> <h4 class="title">Data synthesis</h4> <p>Pooled estimates of treatment effect were derived using the random‐effects model. subgroups and sensitivity analyses were conducted to prove the robustness of the model. All outcomes were dichotomous and the summary estimate as a risk ratio (RR) was presented with 95% CI. </p> </section> <section id="CD010481-sec-0045"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analyses were conducted to explore possible sources of heterogeneity. Heterogeneity in treatments could be related to prior drug(s) used, dose, duration, indication for use of amphotericin B and concomitant nephrotoxic drug use. </p> </section> <section id="CD010481-sec-0046"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were performed to explore the influence of the following factors on effect size: </p> <p> <ul id="CD010481-list-0008"> <li> <p>Repeating the analysis taking risk of bias into account</p> </li> <li> <p>Repeating the analysis excluding any very long or large studies to establish how much they dominate the results </p> </li> <li> <p>Repeating the analysis excluding each study in turn</p> </li> <li> <p>Excluding studies with dose or duration of liposomal amphotericin B off‐label.</p> </li> </ul> </p> <section id="CD010481-sec-0047"> <h5 class="title">Summary of findings table</h5> <p>Results relating to the primary outcome are presented in <a href="./full#CD010481-tbl-0001">summary of findings Table for the main comparison</a>, which also includes an overall assessment of the evidence related to each of the main outcomes using the GRADE approach (<a href="./references#CD010481-bbs2-0042" title="GuyattG , OxmanAD , SchünemannHJ , TugwellP , KnottnerusA . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology2001;64(4):380‐2. [MEDLINE: 21185693] ">Guyatt 2011</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010481-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010481-sec-0048"></div> <section id="CD010481-sec-0049"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD010481-sec-0089" title="">Characteristics of included studies</a> and <a href="./references#CD010481-sec-0090" title="">Characteristics of excluded studies</a> </p> <section id="CD010481-sec-0050"> <h4 class="title">Results of the search</h4> <p>Our search identified 42 records of 33 studies that were assessed as full text articles. Following assessment, 26 records were excluded: 21 investigated interventions that were not relevant to this review and one study was a pharmacoeconomic. We included 12 studies that reported data for 2298 participants in the qualitative synthesis and 10 studies (2172 participants) in the meta‐analyses (<a href="#CD010481-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010481-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD010481-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD010481-sec-0051"> <h4 class="title">Included studies</h4> <p>We included 12 studies (2298 participants) in this review (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>). Ten studies (2172 participants) were meta‐analysed (see <a href="./references#CD010481-sec-0089" title="">Characteristics of included studies</a>). Two studies could not be included in the meta‐analysis: <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a> was the only study which assessed CrCl in mL/min and <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a> only reported rise in SCr (is not possible to know the magnitude of the change respect baseline values). </p> <section id="CD010481-sec-0052"> <h5 class="title">Participants</h5> <p>Participants included suspected or proven systemic fungal infection (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>); HIV or AIDS and cryptococcal meningitis (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>); AIDS and moderate to severe histoplasmosis (<a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>); neutropenia (<a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>); neutropenia and suspected invasive fungal infection (<a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>); neutropenia and fever of unknown origin (<a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>); liver transplantation (<a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>); and signs or symptoms of visceral leishmaniasis (<a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>). </p> <p>Participants' ages were reported in 10 studies (two studies specified numbers of enrolled adults and children as a categorical variable (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>). Two studies did not report participants' sex (<a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>) and <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>reported sex by episode of treatment. </p> </section> <section id="CD010481-sec-0053"> <h5 class="title">Setting</h5> <p>Seven studies were multicentric and five were undertaken in one centre. Ten studies were undertaken in inpatients. The countries included in studies are: India, USA, Canada, Dutch, Australia, France and UK (see <a href="./references#CD010481-sec-0089" title="">Characteristics of included studies</a>). </p> </section> <section id="CD010481-sec-0054"> <h5 class="title">Design</h5> <p>All included studies were RCTs. Eight studies included two arms and four studies were designed around three comparisons: <a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>, <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a> and <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a> investigated two doses of liposomal amphotericin B versus conventional amphotericin B and <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a> included an amphotericin B lipid complex (ABLC) arm, a liposomal amphotericin arm and the control group with conventional amphotericin. </p> </section> <section id="CD010481-sec-0055"> <h5 class="title">Interventions</h5> <p>The comparator in all included studies was conventional amphotericin B (sodium deoxycholate salt); four studies reported the trade name of the treatment received for the control group (Fungizone®) (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>); in nine studies the treatment group received liposomal amphotericin B as amBisome® (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>); and one study (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>) the liposomal formulation was manufactured in‐house at the Seth GS Medical College and King Edward Memorial Hospital in Mumbai (L‐AMP‐LRC‐1). </p> <p> <ul id="CD010481-list-0009"> <li> <p>Three studies compared 1 mg/kg liposomal amphotericin B (L‐AMB) with 1 mg/kg conventional amphotericin B (C‐AMB) (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>). <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a> and <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a> also compared 3 mg/kg L‐AMB with 1 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a> compared 3 mg/kg and 6 mg/kg L‐AMB with 0.7 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a> compared 3 mg/kg L‐AMB with 0.6 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a> compared 3 mg/kg L‐AMB with 0.7 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a> compared 4 mg/kg L‐AMB with 0.7 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a> compared 5 mg/kg L‐AMB with 1 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a> compared 50 mg/d L‐AMB with 15 mg/d C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a> compared 2 mg/kg L‐AMB with 1 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a> compared 10 mg/kg L‐AMB with 1 mg/kg C‐AMB </p> </li> <li> <p><a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a> compared 15 mg/kg L‐AMB with 1 mg/kg C‐AMB. </p> </li> </ul> </p> <p>Premedication to prevent infusion‐related reactions was permitted in eight studies (<a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>), however <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>, <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a> and <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a> allowed premedication before the first dose of the study medication. <a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a> used only IV saline load and <a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a> and <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a> did not report if premedication was allowed. </p> </section> </section> <section id="CD010481-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We excluded 26 records of 21 studies. Of these, 20 studies investigated interventions or comparators outside the scope of this review, and one was a pharmacoeconomic analysis (see <a href="./references#CD010481-sec-0090" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD010481-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, study quality was suboptimal. The risk of bias in included studies was low or unclear for most domains. However, blinding of participants and personnel, blinding of outcome assessment and other bias (funding) tended to have a high risk of bias. See <a href="#CD010481-fig-0002">Figure 2</a> and <a href="#CD010481-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD010481-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD010481-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD010481-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010481-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD010481-sec-0058"> <h4 class="title">Allocation</h4> <p>Seven studies clearly described random sequence generation, and were assessed at low risk of bias (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>). Five studies did not include reporting of sequence generation methods and were deemed at unclear risk (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>). </p> <p>Five studies reported using sealed or closed envelopes, but did not report if envelopes were opaque and sequentially numbered, and were assessed as unclear risk of bias for this domain (<a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>). Four studies did not report on the method of allocation concealment, and were also considered being at unclear risk of bias (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>). Three studies adequately reported concealment methods (<a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>) and were assessed at low risk of bias. </p> </section> <section id="CD010481-sec-0059"> <h4 class="title">Blinding</h4> <p>Three studies (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>, <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>) were double‐blinded and assessed at low risk of bias. Nine studies were assessed at high risk of bias in relation to blinding; of these, four were described as open (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>) and five studies did not report blinding participants or study personnel (<a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>). </p> <p>None of the included studies provided statements about blinding of outcomes assessment. All were assessed at high risk of bias for this domain. </p> </section> <section id="CD010481-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>There was no missing outcome data in six studies (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>) and were assessed at low risk of bias. In one study, assessment was not possible due to the lack of information, so it was also assessed as at unclear risk of bias (<a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>). In three studies (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>) missing outcome data were balanced in numbers across intervention groups and were assessed at low risk of bias. In <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>, missing outcome data for efficacy (an outcome different of the relevant to this review) were explained and the intention‐to‐treat analysis (ITT) was performed, and in one study no patient data were lost in follow‐up (<a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>); these studies were also judged at low risk of bias of attrition bias. </p> </section> <section id="CD010481-sec-0061"> <h4 class="title">Selective reporting</h4> <p>Most study protocols were unobtainable, so judgements were based on the agreement between the methods and the results' of the study's reports. One study was classified at high risk of bias for this domain (<a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>); the study failed to include results for a key outcome (nephrotoxicity) that would be expected to be reported, given that in methods, the authors' statement is that haematological and biochemical parameters were monitored twice weekly, including SCr levels. </p> </section> <section id="CD010481-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a> was assessed as unclear risk of other sources of bias due to insufficient information to permit judgement. </p> <p>Pharmaceutical funding was identified in seven studies (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>) and these studies were assessed at high risk of bias. </p> <p><a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a> and <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a> were assessed at high risk of bias due to an independent sample t‐test, being used to detect differences in clinical and laboratory results (including change in creatinine) for both study groups. Tests for normal distribution were not shown or reported. </p> <p>Although there were relatively few studies included in the meta‐analysis (10), a funnel plot was constructed to assess the potential existence of small study bias (<a href="#CD010481-fig-0004">Figure 4</a>). The plot showed a lack of small studies in favour of the conventional formulation. </p> <div class="figure" id="CD010481-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Comparison between liposomal and conventional amphotericin B, outcome: 1.1 Increase in serum creatinine level ≥ two‐fold increase from baseline level" data-id="CD010481-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Comparison between liposomal and conventional amphotericin B, outcome: 1.1 Increase in serum creatinine level ≥ two‐fold increase from baseline level </p> </div> </div> </div> </section> </section> <section id="CD010481-sec-0063"> <h3 class="title" id="CD010481-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD010481-tbl-0001"><b>Summary of findings for the main comparison</b> Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function</a> </p> <section id="CD010481-sec-0064"> <h4 class="title">Increase in serum creatinine</h4> <p>Ten studies (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>) compared liposomal amphotericin B with conventional amphotericin B and were included in the meta‐analysis. There was a significant increase in SCr level: ≥ two‐fold from baseline level with conventional amphotericin B compared to liposomal amphotericin B (<a href="./references#CD010481-fig-0005" title="">Analysis 1.1</a> (10 studies, 2172 participants): RR 0.49, 95% CI 0.40 ‐ 0.59; I<sup>2</sup> = 0%). </p> <p><a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a> and <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a> were excluded from the meta‐analysis. <a href="./references#CD010481-bbs2-0008" title="ShahT , LaiWK , GowP , LeemingJ , MutimerD . Low‐dose amphotericin for prevention of serious fungal infection following liver transplantation. Transplant Infectious Disease2005;7(3‐4):126‐32. [MEDLINE: 16390401] ">Shah 2005</a> (87 participants) reported the mean CrCl at the start and end of therapy with liposomal and conventional amphotericin B; for liposomal amphotericin B, the starting mean CrCl (mL/min) was 33.65 and at the end was 40.61 (P = 0.661). In the conventional group, the initial mean CrCl was 38.65 and at the end was 44.23 (P = 0.805). <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a> (34 participants) reported rise in SCr of 23% with conventional amphotericin B and 0% with liposomal amphotericin B. We were unsuccessful in our attempts to contact the authors for clarification. </p> </section> <section id="CD010481-sec-0065"> <h4 class="title">Infusion‐related reactions</h4> <p>Nine studies (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; <a href="./references#CD010481-bbs2-0011" title="ThakurCP . A single high dose treatment of kala‐azar with Ambisome (amphotericin B lipid complex): a pilot study. International Journal of Antimicrobial Agents2001;17(1):67‐70. [MEDLINE: 11137652] ">Thakur 2001</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>) compared liposomal amphotericin B with conventional amphotericin B (sodium deoxycholate). There was significant decrease in all infusion‐related reactions in the liposomal group compared with the conventional group (<a href="./references#CD010481-fig-0006" title="">Analysis 1.2</a>): fever (4 studies, 1092 participants): RR 0.39, 95% CI 0.28 to 0.55; I<sup>2</sup> = 32%); chills and/or rigours (5 studies, 1081 participants): RR 0.27, 95% CI 0.15 to 0.48; I<sup>2</sup> = 75%); fever and/or rigours (2 studies, 720 participants): RR 0.68, 95% CI 0.52 to 0.90; I<sup>2</sup> = 58%); nausea (6 studies, 1187 participants): RR 0.50, 95% CI 0.35 to 0.72; I<sup>2</sup> = 0%); and vomiting (3 studies, 1019 participants): RR 0.51, 95% CI 0.27 to 0.95; I<sup>2</sup> = 61%). </p> </section> <section id="CD010481-sec-0066"> <h4 class="title">Sensitivity analyses</h4> <p>Sensitivity analyses were performed to explore the influence of the following factors on effect size. </p> <p>Repeating the analyses taking account of risk of bias: in studies at high risk of bias the difference is not significant (<a href="./references#CD010481-fig-0007" title="">Analysis 2.1</a>; RR 0.16, 95% CI 0.03 to 1.00; I² = 0%); for studies at unclear risk of bias and low risk of bias, the difference is significant (<a href="./references#CD010481-fig-0008" title="">Analysis 2.2</a>; RR 0.39, 95% CI 0.27 to 0.55; I² = 0%) and (<a href="./references#CD010481-fig-0009" title="">Analysis 2.3</a>; RR 0.55, 95% CI 0.44 to 0.69; I² = 0%). </p> <p>Repeating the analyses excluding any very long or large studies to establish how much they dominate the results: We excluded five large studies (1857 participants): <a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>; and <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>. The difference in the increase in SCr level: ≥ two‐fold from baseline level between the two treatments remained significant (<a href="./references#CD010481-fig-0010" title="">Analysis 2.4</a>; RR 0.36, 95% CI 0.22 to 0.58). </p> <p>Repeating the meta‐analysis as many times as RCT included: a sensitivity analysis was conducted as many times as studies included, excluding one study each time. The total effect estimate was statistically significant (<a href="./references#CD010481-fig-0011" title="">Analysis 2.5</a>; RR 0.48, CI 95% 0.45 to 0.52, I² 0%). </p> <p>Excluding studies with dose or duration of liposomal amphotericin B off‐label: Eight studies were compared and the total effect estimate was also statistically significant (<a href="./references#CD010481-fig-0012" title="">Analysis 2.6</a>; RR 0.49, 95% CI 0.41 to 0.59, I² = 0%). </p> </section> <section id="CD010481-sec-0067"> <h4 class="title">Subgroup analysis</h4> <p>Two subgroup analyses were also conducted. One looked at the number of days of treatment (fewer than five days and at least 11 days); the second was based in diagnostic or clinical indication of amphotericin B (IFI/neutropenia, AIDS or HIV infected + cryptococcal meningitis or histoplasmosis and visceral leishmaniasis). Only in the subgroup of fewer than five days of treatment and visceral leishmaniasis (both included the same studies), the difference was not significant (<a href="./references#CD010481-fig-0013" title="">Analysis 3.1</a>.1 (2 studies, 565 participants): RR 0.33, 95% CI 0.06 to 1.68; I<sup>2</sup> = 0%). There is a need to clarify that these two studies (<a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a>) used a dose and therapy duration different from that recommended for visceral leishmaniasis. The first used a dose of 2 mg/kg/d in five consecutive infusions, and the second used a unique dose of amphotericin B of 10 mg/kg. The recommendations state 3 mg/kg/d on days one to five and 3 mg/kg/d on days 14 and 21 for immunocompetent patients, and 4 mg/kg/d on days one to five and 4 mg/kg/d on days 10, 17, 24, 31 and 38 for immunocompromised patients. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010481-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010481-sec-0068"></div> <section id="CD010481-sec-0069"> <h3 class="title" id="CD010481-sec-0069">Summary of main results</h3> <p>We included 12 studies (2298 participants) in this review. Of these, 10 were able to be meta‐analysed (2172 participants). <a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a> evaluated patients with suspected or proven IFI; <a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a> and <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a> included patients with HIV or AIDS and cryptococcal meningitis; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a> also included patients with AIDS but with moderate to severe histoplasmosis. Four studies included patients with neutropenia; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a> included patients with neutropenia only; participants in <a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a> had suspected IFI; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a> and <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a> included neutropenic patients with pyrexia or fever of unknown origin; and <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a> and <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a> included patients with signs or symptoms of visceral leishmaniasis. </p> <p>The primary outcome sought was SCr level increase at least two‐fold from baseline. Ten studies were included in the meta‐analysis for this outcome. For the secondary outcome (infusion‐related reactions) it was possible to obtain information about fever, chills and/or rigours, fever and/or rigours, nausea and vomiting. In all the cases, there were significantly less infusion‐related reactions with liposomal amphotericin B compared to conventional amphotericin B. </p> <p>Overall, risk of bias in included studies was low or unclear for most domains. However, blinding of participants and personnel, blinding of outcome assessment and other bias (funding) tended to have a high risk of bias. <a href="./full#CD010481-tbl-0001">summary of findings Table for the main comparison</a> provides a concise overview and synthesis of the volume and quality of the evidence for the comparison between liposomal and conventional amphotericin B respect to the increase in SCr level ≥ two‐fold from baseline level. Publication bias was not detected and several sensitivity analyses were performed to check the robustness of the effect estimate. </p> </section> <section id="CD010481-sec-0070"> <h3 class="title" id="CD010481-sec-0070">Overall completeness and applicability of evidence</h3> <p>The studies included in this review vary in several aspects (patients (diagnosis or clinical condition), dose of amphotericin received (treatment group and control group), country, risk of bias, methods). However, the patients that would typically receive this treatment are represented. Although two eligible studies were excluded from the meta‐analysis, the included studies allowed us to obtain a clear response for both the primary and secondary outcomes. </p> <p>The results reported in the included studies did not enable post hoc comparisons of renal replacement therapy or end‐stage kidney disease. Although the elevation in SCr levels is considered a clinical manifestation of AKI and it is associated with an increased risk of morbidity and mortality (<a href="./references#CD010481-bbs2-0062" title="YangF , ZhangL , WuH , ZouH , DuY . Clinical analysis of cause, treatment and prognosis in acute kidney injury patients. PLoS One [Electronic Resource]2014;9(2):e85214. [MEDLINE: 24586237] ">Yang 2014</a>), it is a surrogate outcome with poor specificity and sensitivity with regard to recognition of the early period of AKI (<a href="./references#CD010481-bbs2-0061" title="UrbschatA , ObermüllerN , HaferkampA . Biomarkers of kidney injury. Biomarkers2011;16 Suppl 1:S22‐30. [MEDLINE: 21707441] ">Urbschat 2011</a>), and it is uncertain whether reductions in SCr will translate into clinically important benefits. </p> </section> <section id="CD010481-sec-0071"> <h3 class="title" id="CD010481-sec-0071">Quality of the evidence</h3> <p>The results of this review are robust; 10 studies (2172 participants) were included in the meta‐analysis for the primary outcome of which the overall risk of bias was: high for two studies (<a href="./references#CD010481-bbs2-0003" title="JadhavMP , ShindeVM , ChandrakalaS , JijinaF , MenonH , AroraB , et al. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Indian Journal of Cancer2012;49(1):107‐13. [MEDLINE: 22842177] ">Jadhav 2012</a>; <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a>), uncertain for six studies (<a href="./references#CD010481-bbs2-0001" title="BodhePV , KotwaniRN , KirodianBG , KshirsagarNA , PandyaSK . Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. Journal of the Association of Physicians of India2002;50(5):662‐70. [MEDLINE: 12186120] ">Bodhe 2002</a>; <a href="./references#CD010481-bbs2-0005" title="LeendersAC , ReissP , PortegiesP , ClezyK , HopWC , HoyJ , et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis. AIDS1997;11(12):1463‐71. [MEDLINE: 9342068] ">Leenders 1997</a>; <a href="./references#CD010481-bbs2-0006" title="LeendersAC , DaenenS , JansenRL , HopWC , LowenbergB , WijermansPW , et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections. British Journal of Haematology1998;103(1):205‐12. [MEDLINE: 9792309] ">Leenders 1998</a>; <a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a>; <a href="./references#CD010481-bbs2-0004" title="JohnsonPC , WheatLJ , CloudGA , GoldmanM , LancasterD , BambergerDM , et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Annals of Internal Medicine2002;137(2):105‐9. [MEDLINE: 12118965] ">Johnson 2002a</a>; <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a> and low for the other two (<a href="./references#CD010481-bbs2-0002" title="HamillRJ , SobelJD , ElSadrW . Randomized double‐blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients [abstract no:1161]. Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1999 Sept 26‐29; San Francisco, CA. 1999. HamillRJ , SobelJD , El‐SadrW , JohnsonPC , GraybillJR , JavalyK , et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS‐associated acute cryptococcal meningitis: a randomized, double‐blind clinical trial of efficacy and safety. Clinical Infectious Diseases2010;51(2):225‐32. [MEDLINE: 20536366] ">Hamill 2010</a>; <a href="./references#CD010481-bbs2-0012" title="CagnoniPJ . Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Journal of Antimicrobial Chemotherapy2002;49 Suppl 1:81‐6. [MEDLINE: 11801587] CagnoniPJ , HiemenzJ , PrendergastM , ArndtC , BodensteinerD , GreenbergR , et al. Pharmacoeconomic assessment of liposomal amphotericin B versus conventional amphotericin B deoxycholate in the empirical treatment of persistently febrile neutropenic patients [abstract no: 2268]. Journal of Clinical Oncology1999;17:587a. [CENTRAL: CN‐00692141] CagnoniPJ , WalshTJ , PrendergastMM , BodensteinerD , HiemenzS , GreenbergRN , et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.[Erratum appears in J Clin Oncol 2000 Aug;18(16):3064]. Journal of Clinical Oncology2000;18(12):2476‐83. [MEDLINE: 10856108] WalshTJ , FinbergRW , ArndtC , HiemenzJ , SchwartzC , BodensteinerD , et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. New England Journal of Medicine1999;340(10):764‐71. [MEDLINE: 10072411] ">Walsh 1999</a>). The main key methodological limitation of the included studies was the blinding of participants and personnel, blinding of outcome assessment and other bias (funding). Subgroup (<a href="./references#CD010481-fig-0013" title="">Analysis 3.1</a>; <a href="./references#CD010481-fig-0014" title="">Analysis 3.2</a>) and sensitivity analyses (<a href="./references#CD010481-fig-0008" title="">Analysis 2.2</a>; <a href="./references#CD010481-fig-0009" title="">Analysis 2.3</a>; <a href="./references#CD010481-fig-0010" title="">Analysis 2.4</a>; <a href="./references#CD010481-fig-0011" title="">Analysis 2.5</a>) indicated that the magnitude and direction of the effect did not change, except in studies at high risk of bias (<a href="./references#CD010481-fig-0007" title="">Analysis 2.1</a>) and when <a href="./references#CD010481-bbs2-0009" title="SundarS , MehtaH , SureshAV , SinghSP , RaiM , MurrayHW . Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clinical Infectious Diseases2004;38(3):377‐83. [MEDLINE: 14727208] ">Sundar 2004</a> and <a href="./references#CD010481-bbs2-0010" title="SundarS , ChakravartyJ , AgarwalD , RaiM , MurrayHW . Single‐dose liposomal amphotericin B for visceral leishmaniasis in India. New England Journal of Medicine2010;362(6):504‐12. [MEDLINE: 20147716] ">Sundar 2010</a> were analysed separately. These studies were conducted in patients with visceral leishmaniasis, with treatment doses and duration that differed from the liposomal formulation product information (off‐label). </p> <p><a href="./references#CD010481-bbs2-0048" title="JohansenHK , GøtzschePC . Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD000969.pub2] ">Johansen 2014</a> concluded that it was unclear if these formulations (all lipid‐based amphotericin B formulations) offered advantages, if conventional amphotericin B is administered under optimal circumstances; in nine of the 10 included studies in this review, loading saline or premedication with antipyretics or antihistamines were allowed for prevention of infusion‐related reactions and nephrotoxicity in the control groups and in some of the treatment groups. </p> </section> <section id="CD010481-sec-0072"> <h3 class="title" id="CD010481-sec-0072">Potential biases in the review process</h3> <p>In addition to electronic searching of bibliographic databases without language restriction, other strategies included contacting study authors and accessing registers of ongoing studies. Although searches were comprehensive, and we did not find evidence of publication bias (<a href="#CD010481-fig-0004">Figure 4</a>), two potentially eligible studies were excluded because we were unable to extract or obtain key outcomes data. However it is unlikely that addition of unpublished data would substantially change our overall review findings. </p> <p><a href="./references#CD010481-bbs2-0007" title="PrenticeHG , HannIM , HerbrechtR , AounM , KvaloyS , CatovskyD , et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology1997;98(3):711‐8. [MEDLINE: 9332329] ">Prentice 1997</a> reported nephrotoxicity incidence and accounted for use of concomitant nephrotoxic drugs with amphotericin B. This study did not find any differences in the subgroup of patients receiving concomitant nephrotoxic drugs (P = 0.11). This finding is relevant because it is pharmacologically and clinically plausible that treatment involving more than one nephrotoxic drug increases the likelihood of kidney failure, and this should be considered in treatment choices. </p> </section> <section id="CD010481-sec-0073"> <h3 class="title" id="CD010481-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>Our findings agree with <a href="./references#CD010481-bbs2-0048" title="JohansenHK , GøtzschePC . Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD000969.pub2] ">Johansen 2014</a>, who reported decreased nephrotoxicity (defined as 100% increase in SCr) associated with the liposomal formulation (RR 0.45, 95% CI 0.37 to 0.54). <a href="./references#CD010481-bbs2-0052" title="MistroS , Maciel IdeM , deMenezesRG , MaiaZP , SchooleyRT , BadaroR . Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta‐analysis. Clinical Infectious Diseases2012;54(12):1774‐7. [MEDLINE: 22491505] ">Mistro 2012</a> also suggested that liposomal amphotericin B reduced nephrotoxicity (RR 0.48; 95% CI 0.36 to 0.64). <a href="./references#CD010481-bbs2-0052" title="MistroS , Maciel IdeM , deMenezesRG , MaiaZP , SchooleyRT , BadaroR . Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta‐analysis. Clinical Infectious Diseases2012;54(12):1774‐7. [MEDLINE: 22491505] ">Mistro 2012</a> included five studies all of which were included in our review. <a href="./references#CD010481-bbs2-0048" title="JohansenHK , GøtzschePC . Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD000969.pub2] ">Johansen 2014</a> included three studies, all of which were also included in this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010481-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD010481-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD010481-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010481-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Comparison between liposomal and conventional amphotericin B, outcome: 1.1 Increase in serum creatinine level ≥ two‐fold increase from baseline level" data-id="CD010481-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Comparison between liposomal and conventional amphotericin B, outcome: 1.1 Increase in serum creatinine level ≥ two‐fold increase from baseline level </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Liposomal versus conventional amphotericin B, Outcome 1 Increase in serum creatinine level ≥ two‐fold increase from baseline level." data-id="CD010481-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Liposomal versus conventional amphotericin B, Outcome 1 Increase in serum creatinine level ≥ two‐fold increase from baseline level. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Liposomal versus conventional amphotericin B, Outcome 2 Infusion‐related reactions (as determined by the investigators)." data-id="CD010481-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Liposomal versus conventional amphotericin B, Outcome 2 Infusion‐related reactions (as determined by the investigators). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis for the primary outcome, Outcome 1 Overall risk of bias: high." data-id="CD010481-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis for the primary outcome, Outcome 1 Overall risk of bias: high. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis for the primary outcome, Outcome 2 Overall risk of bias: unclear." data-id="CD010481-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis for the primary outcome, Outcome 2 Overall risk of bias: unclear. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis for the primary outcome, Outcome 3 Overall risk of bias: low." data-id="CD010481-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis for the primary outcome, Outcome 3 Overall risk of bias: low. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis for the primary outcome, Outcome 4 Excluding large studies." data-id="CD010481-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis for the primary outcome, Outcome 4 Excluding large studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis for the primary outcome, Outcome 5 Sensitivity analysis excluding one study at a time." data-id="CD010481-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis for the primary outcome, Outcome 5 Sensitivity analysis excluding one study at a time. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis for the primary outcome, Outcome 6 Excluding studies with off‐label use of liposomal amphotericin B." data-id="CD010481-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis for the primary outcome, Outcome 6 Excluding studies with off‐label use of liposomal amphotericin B. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis, Outcome 1 Duration of the treatment." data-id="CD010481-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis, Outcome 1 Duration of the treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010481-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/urn:x-wiley:14651858:media:CD010481:CD010481-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_t/tCD010481-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis, Outcome 2 Diagnostic or clinical indication." data-id="CD010481-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis, Outcome 2 Diagnostic or clinical indication.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/media/CDSR/CD010481/image_n/nCD010481-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010481-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Increase in serum creatinine (SCr) level ≥ two‐fold from baseline level</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients in treatment with amphotericin B<br/> <b>Settings:</b> inpatients<br/> <b>Intervention:</b> liposomal amphotericin B<br/> <b>Comparison:</b> conventional amphotericin B </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Conventional amphotericin B</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Liposomal amphotericin B</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Increase in SCr level: ≥ two‐fold from baseline level</b> <br/> SCr level (mg/dL) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.49</b> <br/> (0.40 to 0.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2172 (10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕<br/> <b>Moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>261 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>128 per 1000</b> <br/> (105 to 154) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The results obtained are consistent; sensitivity analysis was performed to see the influence of several factors in the effect estimate, however, the magnitude, the direction and the significance didn't change. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/full#CD010481-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010481-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Liposomal versus conventional amphotericin B</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Increase in serum creatinine level ≥ two‐fold increase from baseline level <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.40, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Infusion‐related reactions (as determined by the investigators) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1092</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.28, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Chills and/or rigours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1081</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.15, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Fever and/or rigours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.52, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.35, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.27, 0.95]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Liposomal versus conventional amphotericin B</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010481-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis for the primary outcome</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall risk of bias: high <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.03, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Overall risk of bias: unclear <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.27, 0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall risk of bias: low <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.44, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Excluding large studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.22, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Sensitivity analysis excluding one study at a time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Excluded Leenders 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.40, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Excluded Prentice1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.38, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Excluded Leenders 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2066</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.41, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Excluded Walsh 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.32, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Excluded Johnson 2002a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.41, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Excluded Bodhe 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.36, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 Excluded Sundar 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.41, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8 Excluded Hamill 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1915</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.34, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9 Excluded Sundar 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1770</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.37, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10 Excluded Jadhav 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.39, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Excluding studies with off‐label use of liposomal amphotericin B <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1607</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.41, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis for the primary outcome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010481-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of the treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.40, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Fewer than 5 days of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.06, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 At least 11 days of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1607</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.41, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Diagnostic or clinical indication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Invasive fungal infection/neutropenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.40, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 AIDS or HIV infected + cryptococcal meningitis or histoplasmosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.03, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Visceral leishmaniasis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.06, 1.68]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010481.pub2/references#CD010481-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010481.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010481-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010481-note-0004">فارسی</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010481\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010481\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010481\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010481\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=urvLIhM4&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010481.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010481.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010481.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010481.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010481.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724726493"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010481.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724726497"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010481.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e69df4b371c00',t:'MTc0MDcyNDcyNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 